Inventor · Tampa, FL, US

Mark McLaughlin

27Patents
4h-index
49Co-inventors
63Inventor score

Filing activity: Feb 7, 1990 → Jun 2, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US5789542A Amphipathic peptides Human Necessities 45 Expired
US6566334B1 Short amphipathic peptides with activity against bacteria and intracellular pathogens Emerging Cross-Sectional Technologies 14 Expired
US8853149B2 Integrin interaction inhibitors for the treatment of cancer Human Necessities 6 Active
US7262163B2 Short amphipathic peptides with activity against bacteria and intracellular pathogens Emerging Cross-Sectional Technologies 5 Expired
US10011635B2 Cyclic peptide conjugates and methods of use Chemistry; Metallurgy 3 Active
US10059740B2 Integrin interaction inhibitors for the treatment of cancer Human Necessities 2 Active
US5068469A Process for preparation of condensed alcohols by alkoxide catalysts Chemistry; Metallurgy 2 Expired
US10793595B2 Toll-like receptor 2 ligands and methods of making and using thereof Human Necessities 2 Active
US10449227B2 Conjugates for immunotherapy Chemistry; Metallurgy 2 Active
US10118942B2 Toll-like receptor 2 ligands and methods of making and using thereof Human Necessities 2 Active
US11078235B2 Cyclic peptide conjugates and methods of use Chemistry; Metallurgy 1 Active
US11414455B2 Toll-like receptor 2 ligands and methods of making and using thereof Human Necessities 0 Active
US10053466B2 Process for preparing chiral dipeptidyl peptidase-IV inhibitors Chemistry; Metallurgy 0 Active
US10197575B2 Stabilized peptoid-peptide hybrids and uses thereof Emerging Cross-Sectional Technologies 0 Active
US10426843B2 Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer Human Necessities 0 Active
US10556928B2 Stabilized peptoid-peptide hybrids and uses thereof Emerging Cross-Sectional Technologies 0 Active
US9862725B2 Process for preparing chiral dipeptidyl peptidase-IV inhibitors Chemistry; Metallurgy 0 Active
US11406723B2 Radiotherapeutic and companion imaging agents to target MC1R Emerging Cross-Sectional Technologies 0 Active
US10392353B2 Processes for making substituted quinazoline compounds using hydrogen bonding catalysts Human Necessities 0 Active
US12291724B2 Tumor-infiltrating lymphocytes for adoptive cell therapy Chemistry; Metallurgy 0 Active
US9409927B2 Super lewis acidic borate esters as 18F-labeled PET probes Chemistry; Metallurgy 0 Active
US11123435B2 TLR9 targeted therapeutics Chemistry; Metallurgy 0 Active
US12060438B2 Cyclic peptide compounds and methods of use thereof Human Necessities 0 Active
US11518980B2 Tumor-infiltrating lymphocytes for adoptive cell therapy Chemistry; Metallurgy 0 Active
US12186404B2 Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.